Chancellor
Vein & Lymphatic University
Lake Worth Beach, Florida
SESSION 67: SUPERFICIAL VEIN TREATMENT STRATEGIES II
Session Moderator
SESSION 69: SUPERFICIAL VEIN TREATMENT STRATEGIES IV
Presenter
SESSION 67: SUPERFICIAL VEIN TREATMENT STRATEGIES II
Non-Compounded Polidocanol 1% Endovenous Microfoam (Varithena) Or Thermal Ablation: A Network Meta-Analysis
10:10 AM - 10:15 AM
Presenter
SESSION 69: SUPERFICIAL VEIN TREATMENT STRATEGIES IV
New Superficial Venous Devices: Pre FDA Approval
1:31 PM - 1:36 PM
Presenter
SESSION 69: SUPERFICIAL VEIN TREATMENT STRATEGIES IV
Varithena Meta-Analysis “RELOADED”, The Living Approach
1:55 PM - 2:00 PM
Session Moderator
SESSION 95: DEEP VENOUS PHYSIOLOGY AND VENOUS STENT ISSUES
Session Moderator
SESSION 97: FEMORO-ILIOCAVAL CHRONIC TOTAL OCCLUSIONS, RECANALIZATION TECHNIQUES AND OTHER CONSIDERATIONS
Presenter
SESSION 95: DEEP VENOUS PHYSIOLOGY AND VENOUS STENT ISSUES
Introduction: Deep System
7:30 AM - 7:34 AM
Presenter
SESSION 97: FEMORO-ILIOCAVAL CHRONIC TOTAL OCCLUSIONS, RECANALIZATION TECHNIQUES AND OTHER CONSIDERATIONS
Veins Aren’t Round – Stented Veins Don’t Need To Be Either
9:59 AM - 10:04 AM
CONTROVERSIES IN VENOUS DISEASE MANAGEMENT
WEDNESDAY, NOVEMBER 20, 2024
AMERICAS HALL 1, 3RD FLOOR
MODERATOR
10:00 AM - 12:00 PM
PRESENTER
10:15 AM - 10:20 AM
Non-Refluxing ASV + Refluxing GSV Should NOT Be Treated In One Setting
WEDNESDAY, NOVEMBER 20, 2024
AMERICAS HALL 1, 3RD FLOOR
MODERATOR
10:00 AM - 12:00 PM
PRESENTER
10:15 AM - 10:20 AM
Non-Refluxing ASV + Refluxing GSV Should NOT Be Treated In One Setting